Systemic sclerosis (SSc) is a systemic autoimmune disease affecting multiple organ
systems, including the lungs. Interstitial lung disease (ILD) is the leading cause of death in …

Some of the most pressing challenges associated with interstitial lung disease (ILD) are how
best to define, diagnose, and treat connective tissue disease-associated ILD (CTD-ILD) …

The term interstitial lung abnormalities refers to specific CT findings that are potentially
compatible with interstitial lung disease in patients without clinical suspicion of the disease …

Purpose To determine the prevalence of interstitial lung abnormalities (ILAs) at initial
computed tomography (CT) examination and the rate of progression of ILAs on 2-year follow …

Objective Validated methods for the screening and early diagnosis of systemic sclerosis
(SSc; scleroderma)–related interstitial lung disease (ILD) are needed. The aim of this study …

Rationale: Interstitial lung disease (ILD), a leading cause of morbidity and mortality in
rheumatoid arthritis (RA), is highly prevalent, yet RA-ILD is underrecognized. Objectives: To …

Subtle interstitial changes in the lung parenchyma of smokers, known as Interstitial Lung
Abnormalities (ILA), have been associated with clinical outcomes, including mortality, even …

The connective tissue diseases (CTDs) demonstrating features of interstitial lung disease
(ILD) include systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), progressive …

Evidence suggests that lung injury, inflammation and extracellular matrix remodelling
precede lung fibrosis in interstitial lung disease (ILD). We examined whether a quantitative …

Rationale: Incidental parenchymal abnormalities detected on chest computed tomography
scans are termed interstitial lung abnormalities (ILAs). ILAs may represent early interstitial …